Fundz

Holmusk reported raising $30 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEOct 12, 2023

Amount Raised

$30 Million

$30 Million sold, per SEC Form D (first sale Sep 29, 2023)

Round Type

Venture

New YorkInformation TechnologySoftwareData And AnalyticsMobileHealth Care

Who else raised in Data And Analytics and Mobile around the same time

Companies in the same sectors as Holmusk that raised within 45 days of this round, from Fundz verified event records.

  • Kythera Labs raised $20M (Funding Round) on November 7, 2023.
  • Zephyr AI, Inc. raised $111M on October 27, 2023.
  • SURGLASSES raised $6.5M (Funding Round) on November 9, 2023.
  • MobileX raised $949K (Seed) on November 8, 2023.
  • Vendelux Inc. raised $14M on November 6, 2023.
  • Covera Health raised $50M (Series C) on November 1, 2023.

Who to call at Holmusk, and when

A new round usually means Holmusk is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Holmusk raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Holmusk, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Holmusk. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Holmusk

Location

New York, United States

About

Holmusk is on a mission to reinvent behavioral health and transform lives with Real-World Evidence and digital innovation. Headquartered in Singapore and New York, Holmusk generates evidence and builds digital solutions to advance behavioral health research, innovation, and care. NeuroBlu, Holmusk's flagship product, synthesizes Real-World Data (RWD) with seamless analytic tools, enabling users to create actionable insights that drive behavioral health transformation. NeuroBlu is powered by an industry-leading and continually growing behavioral health clinical dataset, with over 20 years of data on over half a million patients and 20+ million encounters. Holmusk uses advanced proprietary analytics to enrich the data, with Natural Language Processing and predictive disease models designed specifically for behavioral health. Holmusk augments its data and analytic offerings with powerful digital solutions that enhance patient engagement, support disease self-management, and capture patient-reported outcomes to help guide clinical decisions and analytics. For more information, please visit www.holmusk.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Holmusk raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsNawal R., Ceo And Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Holmusk's next move

See what Strategic adds

Holmusk raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.